Oral glucose tolerance and insulin sensitivity are unaffected by HIV infection or antiretroviral therapy in overweight women

Ann Danoff, Qiuhu Shi, Jessica Justman, Kathleen Mulligan, Nancy Hessol, Esther Robison, Dalian Lu, Tania Williams, Paula Wichienkuer, Kathryn Anastos

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Objective: To assess the frequency of diabetes, prediabetes, and insulin resistance among a subset of participants in the Women's Interagency HIV Study (WIHS). Design: Cross-sectional substudy nested within a prospective multicenter cohort study. Women underwent 75 g oral glucose tolerance testing. Diagnoses of diabetes and prediabetes were made according to the American Diabetes Association criteria, and insulin resistance was determined by area under the curve insulin and homeostasis model assessment values. Setting: Six urban clinical sites in the United States (Brooklyn, NY; Bronx, NY; Washington, DC; Chicago, IL; San Francisco, CA; Los Angeles, CA) participate in the entire WIHS. The Bronx, NY, and San Franscisco, CA, WIHS sites participated in this substudy. Participants: A total of 258 women, 88 HIV negative, 74 HIV positive not on highly active antiretroviral therapy (HAART), and 96 HIV positive taking HAART were enrolled in the study. Main Outcomes: Prevalence of diabetes, prediabetes, and insulin resistance was compared among the HIV-uninfected and HIV-infected women. Results: The frequency of diabetes, prediabetes, or insulin resistance was unrelated to HIV status or antiretroviral treatment. Increasing body mass index was the only characteristic associated with the combined endpoints of diabetes and prediabetes (odds ratio = 1.104, P = 0.0002). Conclusions: Routine oral glucose tolerance testing of HIV-infected women is not supported by these findings. Elucidation of putative perturbations from HIV or antiretroviral medications requires direct studies of insulin resistance and β-cell function.

Original languageEnglish (US)
Pages (from-to)55-62
Number of pages8
JournalJournal of Acquired Immune Deficiency Syndromes
Volume39
Issue number1
DOIs
StatePublished - May 1 2005

Fingerprint

Glucose Tolerance Test
HIV Infections
Insulin Resistance
HIV
Prediabetic State
Therapeutics
Highly Active Antiretroviral Therapy
San Francisco
Los Angeles
Multicenter Studies
Area Under Curve
Body Mass Index
Homeostasis
Cohort Studies
Odds Ratio
Insulin

Keywords

  • Diabetes
  • Highly active antiretroviral therapy
  • HIV
  • Insulin resistance

ASJC Scopus subject areas

  • Virology
  • Immunology

Cite this

Oral glucose tolerance and insulin sensitivity are unaffected by HIV infection or antiretroviral therapy in overweight women. / Danoff, Ann; Shi, Qiuhu; Justman, Jessica; Mulligan, Kathleen; Hessol, Nancy; Robison, Esther; Lu, Dalian; Williams, Tania; Wichienkuer, Paula; Anastos, Kathryn.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 39, No. 1, 01.05.2005, p. 55-62.

Research output: Contribution to journalArticle

Danoff, Ann ; Shi, Qiuhu ; Justman, Jessica ; Mulligan, Kathleen ; Hessol, Nancy ; Robison, Esther ; Lu, Dalian ; Williams, Tania ; Wichienkuer, Paula ; Anastos, Kathryn. / Oral glucose tolerance and insulin sensitivity are unaffected by HIV infection or antiretroviral therapy in overweight women. In: Journal of Acquired Immune Deficiency Syndromes. 2005 ; Vol. 39, No. 1. pp. 55-62.
@article{7efb928682b347e9bee84fcddd00c000,
title = "Oral glucose tolerance and insulin sensitivity are unaffected by HIV infection or antiretroviral therapy in overweight women",
abstract = "Objective: To assess the frequency of diabetes, prediabetes, and insulin resistance among a subset of participants in the Women's Interagency HIV Study (WIHS). Design: Cross-sectional substudy nested within a prospective multicenter cohort study. Women underwent 75 g oral glucose tolerance testing. Diagnoses of diabetes and prediabetes were made according to the American Diabetes Association criteria, and insulin resistance was determined by area under the curve insulin and homeostasis model assessment values. Setting: Six urban clinical sites in the United States (Brooklyn, NY; Bronx, NY; Washington, DC; Chicago, IL; San Francisco, CA; Los Angeles, CA) participate in the entire WIHS. The Bronx, NY, and San Franscisco, CA, WIHS sites participated in this substudy. Participants: A total of 258 women, 88 HIV negative, 74 HIV positive not on highly active antiretroviral therapy (HAART), and 96 HIV positive taking HAART were enrolled in the study. Main Outcomes: Prevalence of diabetes, prediabetes, and insulin resistance was compared among the HIV-uninfected and HIV-infected women. Results: The frequency of diabetes, prediabetes, or insulin resistance was unrelated to HIV status or antiretroviral treatment. Increasing body mass index was the only characteristic associated with the combined endpoints of diabetes and prediabetes (odds ratio = 1.104, P = 0.0002). Conclusions: Routine oral glucose tolerance testing of HIV-infected women is not supported by these findings. Elucidation of putative perturbations from HIV or antiretroviral medications requires direct studies of insulin resistance and β-cell function.",
keywords = "Diabetes, Highly active antiretroviral therapy, HIV, Insulin resistance",
author = "Ann Danoff and Qiuhu Shi and Jessica Justman and Kathleen Mulligan and Nancy Hessol and Esther Robison and Dalian Lu and Tania Williams and Paula Wichienkuer and Kathryn Anastos",
year = "2005",
month = "5",
day = "1",
doi = "10.1097/01.qai.0000147659.80642.5a",
language = "English (US)",
volume = "39",
pages = "55--62",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Oral glucose tolerance and insulin sensitivity are unaffected by HIV infection or antiretroviral therapy in overweight women

AU - Danoff, Ann

AU - Shi, Qiuhu

AU - Justman, Jessica

AU - Mulligan, Kathleen

AU - Hessol, Nancy

AU - Robison, Esther

AU - Lu, Dalian

AU - Williams, Tania

AU - Wichienkuer, Paula

AU - Anastos, Kathryn

PY - 2005/5/1

Y1 - 2005/5/1

N2 - Objective: To assess the frequency of diabetes, prediabetes, and insulin resistance among a subset of participants in the Women's Interagency HIV Study (WIHS). Design: Cross-sectional substudy nested within a prospective multicenter cohort study. Women underwent 75 g oral glucose tolerance testing. Diagnoses of diabetes and prediabetes were made according to the American Diabetes Association criteria, and insulin resistance was determined by area under the curve insulin and homeostasis model assessment values. Setting: Six urban clinical sites in the United States (Brooklyn, NY; Bronx, NY; Washington, DC; Chicago, IL; San Francisco, CA; Los Angeles, CA) participate in the entire WIHS. The Bronx, NY, and San Franscisco, CA, WIHS sites participated in this substudy. Participants: A total of 258 women, 88 HIV negative, 74 HIV positive not on highly active antiretroviral therapy (HAART), and 96 HIV positive taking HAART were enrolled in the study. Main Outcomes: Prevalence of diabetes, prediabetes, and insulin resistance was compared among the HIV-uninfected and HIV-infected women. Results: The frequency of diabetes, prediabetes, or insulin resistance was unrelated to HIV status or antiretroviral treatment. Increasing body mass index was the only characteristic associated with the combined endpoints of diabetes and prediabetes (odds ratio = 1.104, P = 0.0002). Conclusions: Routine oral glucose tolerance testing of HIV-infected women is not supported by these findings. Elucidation of putative perturbations from HIV or antiretroviral medications requires direct studies of insulin resistance and β-cell function.

AB - Objective: To assess the frequency of diabetes, prediabetes, and insulin resistance among a subset of participants in the Women's Interagency HIV Study (WIHS). Design: Cross-sectional substudy nested within a prospective multicenter cohort study. Women underwent 75 g oral glucose tolerance testing. Diagnoses of diabetes and prediabetes were made according to the American Diabetes Association criteria, and insulin resistance was determined by area under the curve insulin and homeostasis model assessment values. Setting: Six urban clinical sites in the United States (Brooklyn, NY; Bronx, NY; Washington, DC; Chicago, IL; San Francisco, CA; Los Angeles, CA) participate in the entire WIHS. The Bronx, NY, and San Franscisco, CA, WIHS sites participated in this substudy. Participants: A total of 258 women, 88 HIV negative, 74 HIV positive not on highly active antiretroviral therapy (HAART), and 96 HIV positive taking HAART were enrolled in the study. Main Outcomes: Prevalence of diabetes, prediabetes, and insulin resistance was compared among the HIV-uninfected and HIV-infected women. Results: The frequency of diabetes, prediabetes, or insulin resistance was unrelated to HIV status or antiretroviral treatment. Increasing body mass index was the only characteristic associated with the combined endpoints of diabetes and prediabetes (odds ratio = 1.104, P = 0.0002). Conclusions: Routine oral glucose tolerance testing of HIV-infected women is not supported by these findings. Elucidation of putative perturbations from HIV or antiretroviral medications requires direct studies of insulin resistance and β-cell function.

KW - Diabetes

KW - Highly active antiretroviral therapy

KW - HIV

KW - Insulin resistance

UR - http://www.scopus.com/inward/record.url?scp=20944437462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20944437462&partnerID=8YFLogxK

U2 - 10.1097/01.qai.0000147659.80642.5a

DO - 10.1097/01.qai.0000147659.80642.5a

M3 - Article

C2 - 15851914

AN - SCOPUS:20944437462

VL - 39

SP - 55

EP - 62

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 1

ER -